Home
Conditions
Follicular Lymphoma

Clinical trial condition

Follicular Lymphoma

Explore clinical trials studying Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

231 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Follicular Lymphoma trial results

Completed

A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)

NCT01953692

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +27 more
Locations: Not specified

View Trial Details

Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

NCT00406809

Conditions: Chronic Lymphoid Leukemia, Follicular Lymphoma, Hematologic Diseases, +25 more
Locations: Site Reference ID/Investigator# 4997 Los Angeles, California, United States

Site Reference ID/Investigator# 9104 Los Angeles, California, United States

Site Reference ID/Investigator# 2613 Bethesda, Maryland, United States

Site Reference ID/Investigator# 40243 Boston, Massachusetts, United States

View Trial Details

Completed

A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma

NCT00794638

Conditions: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +14 more
Locations: Nagoya, Aichi-ken, Japan

Isehara, Kanagawa, Japan

Kyoto, Japan

Chuo-ku, Tokyo, Japan

View Trial Details

Completed

GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)

NCT01419665

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Investigative site La Plata, Argentina

Investigative site Rosario, Argentina

Investigative site San Miguel de Tucumán, Argentina

Investigative site Adelaide, Australia

View all 153 locations

View Trial Details

Completed

To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma

NCT02260804

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Severance Hospital Seoul, South Korea

View Trial Details

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

NCT02242045

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +24 more
Locations: Aichi, Japan

Miyagi, Japan

Tokyo, Japan

View Trial Details

Completed

Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma

NCT02677155

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Oslo University Hospital Radiumhospitalet Oslo, Norway

View Trial Details

Completed

Peptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular Lymphoma

NCT03381768

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Herlev Hospital Herlev, RegionH, Denmark

View Trial Details

Completed

Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL

NCT04160442

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma

NCT01275209

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States

Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States

Duke University Medical Center Duke Hem & Onc Durham, North Carolina, United States

Sarah Cannon Research Institute SC - 2 Chattanooga, Tennessee, United States

View Trial Details

Follicular Lymphoma

Follicular Lymphoma trial results

Related conditions